Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy

Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy

Nitric oxide (NO), as a gaseous therapeutic agent, shows great potential for the treatment of many kinds of diseases. Although various NO delivery systems have emerged, the immunogenicity and long-term toxicity of artificial carriers hinder the potential clinical translation of these gas therapeutic...

Full description

Bibliographic Details
Main Authors: Haoyan Huang, Meng Qian, Yue Liu, Shang Chen, Huifang Li, Zhibo Han, Zhong-Chao Han, Xiang-Mei Chen, Qiang Zhao, Zongjin Li
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2023-09-01
Series:eLife
Subjects:
nitric oxide
gaseous signaling molecule
genetically engineered mesenchymal stem cell
acute kidney injury
controlled release
delivery
Online Access:https://elifesciences.org/articles/84820

Internet

https://elifesciences.org/articles/84820

Similar Items